Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by AKIRA IIZUKA
YKL-40 Downregulation Is a Key Factor to Overcome Temozolomide Resistance in a Glioblastoma Cell Line
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
Metformin and Temozolomide, a Synergic Option to Overcome Resistance in Glioblastoma Multiforme Models
Oncotarget
Oncology
Chronic Physiological Hypoxia and High Glucose Concentration Promote Resistance of T98G Glioblastoma Cell Line to Temozolomide
Drug Designing: Open Access
YKL-40 Expression Is Associated With Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma
Clinical Cancer Research
Cancer Research
Oncology
A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
Neurologia Medico-Chirurgica
Surgery
Neurology
Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
Frontiers in Pharmacology
Pharmacology
Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Genetic Alterations Associated With Acquired Temozolomide Resistance in SNB-19, a Human Glioma Cell Line
Molecular Cancer Therapeutics
Cancer Research
Oncology
Epidermal Growth Factor (EGF) Induces a Phenotypic Switch of a Human Glioblastoma Cell Line to Neurospheres
Microscopy and Microanalysis
Instrumentation